Knoll Capital Management, LLC Bio Xcel Therapeutics, Inc. Transaction History

Knoll Capital Management, LLC

  • $203 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$2.49 - $11.85 $74,700 - $355,500
30,000 Added 100.0%
60,000 $151,000
Q2 2023

Aug 15, 2023
BUY
$6.39 - $28.58 $191,700 - $857,400
30,000 New
30,000 $199,000
Q1 2020

May 15, 2020
BUY
$12.26 - $41.14 $245,200 - $822,800
20,000 New
20,000 $447,000

Others Institutions Holding BTAI

# of Institutions
55
Shares Held
3.14M
Call Options Held
22.2K
Put Options Held
40.2K
View Full List

About BioXcel Therapeutics, Inc.

BTAI Quotes by TradingView
  • Ticker BTAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,022,500
  • Market Cap $14.3M
  • Description
  • BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...
More about BTAI
Track This Portfolio

Track Knoll Capital Management, LLC Portfolio

Follow Knoll Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Knoll Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Knoll Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email